Literature DB >> 27812262

Membranoproliferative Glomerulonephritis Secondary to a Low-Grade Lymphoproliferative Disorder: A Rare Cause of Renal Dysfunction.

Tushar Sehgal1, Nidhi Jain1, Gaurav Prakash1, Ritambhra Duseja2, Neelam Varma1.   

Abstract

Chronic lymphocytic leukemia is a B-cell neoplasm with an indolent clinical course. Most patients are asymptomatic and are diagnosed incidentally on a routine blood count. The malignant cells of this low-grade neoplasm infiltrate various organs and tissues. However, the resultant end organ damage is a rare phenomenon. Here we describe a case of chronic lymphocytic leukemia that presented with an unusual cause of acute renal dysfunction. The patient had deranged renal parameters with a nephrotic range proteinuria. The uncommon cause for his renal problem was membranoproliferative glomerulonephritis diagnosed by performing a kidney biopsy. Moreover, the acute renal dysfunction in this patient mandated an appropriate treatment and as of now there are no well-established treatment protocols for chronic lymphocytic leukemia with nephrotic syndrome. The patient was successfully treated with rituximab and bendamustine based on the expertise and judgement of the clinician.

Entities:  

Keywords:  Chronic lymphocytic leukemia; Membranoproliferative glomerulonephritis; Renal dysfunction; Treatment

Year:  2016        PMID: 27812262      PMCID: PMC5074978          DOI: 10.1007/s12288-016-0697-4

Source DB:  PubMed          Journal:  Indian J Hematol Blood Transfus        ISSN: 0971-4502            Impact factor:   0.900


  7 in total

1.  Membranoproliferative glomerulonephritis secondary to monoclonal gammopathy.

Authors:  Sanjeev Sethi; Ladan Zand; Nelson Leung; Richard J H Smith; Dragan Jevremonic; Sandra S Herrmann; Fernando C Fervenza
Journal:  Clin J Am Soc Nephrol       Date:  2010-02-25       Impact factor: 8.237

Review 2.  Narrative review: initial management of newly diagnosed, early-stage chronic lymphocytic leukemia.

Authors:  Tait D Shanafelt; John C Byrd; Timothy G Call; Clive S Zent; Neil E Kay
Journal:  Ann Intern Med       Date:  2006-09-19       Impact factor: 25.391

3.  Renal involvement in myeloproliferative and lymphoproliferative disorders. A study of autopsy cases.

Authors:  J C Xiao; R Walz-Mattmüller; P Ruck; H P Horny; E Kaiserling
Journal:  Gen Diagn Pathol       Date:  1997-02

Review 4.  Nephrotic syndrome associated with chronic lymphocytic leukemia resistant to immunosuppressive drugs: remission obtained by splenectomy.

Authors:  J M Halimi; T Lavabre-Bertrand; J J Beraud; B Canaud
Journal:  Clin Nephrol       Date:  1996-04       Impact factor: 0.975

5.  Membranoproliferative glomerulonephritis and light-chain nephropathy in association with chronic lymphocytic leukemia.

Authors:  R Mutluay; S Zeynep Aki; Y Erten; C Konca; M Yagci; G Barit; S Sindel
Journal:  Clin Nephrol       Date:  2008-12       Impact factor: 0.975

6.  Chronic lymphocytic leukaemia and small lymphocytic lymphoma: overview of the descriptive epidemiology.

Authors:  Graça M Dores; William F Anderson; Rochelle E Curtis; Ola Landgren; Evgenia Ostroumova; Elizabeth C Bluhm; Charles S Rabkin; Susan S Devesa; Martha S Linet
Journal:  Br J Haematol       Date:  2007-10-17       Impact factor: 6.998

7.  [Successful treatment with fludarabine of chronic lymphocytic leukemia associated with nephrotic syndrome].

Authors:  Kazuhiro Takei; Akira Horikoshi; Yoshifumi Hosokawa; Shigemasa Sawada; Takashi Horie
Journal:  Rinsho Ketsueki       Date:  2002-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.